The debate over NHS top-up fees, and whether people should be able to buy better healthcare, is an ethical minefield. It’s also a massive business opportunity for the insurance industry. As the government appears to be relenting on its opposition to top-ups, I wrote for Insurance Times about how the NHS might change, and spoke to the insurers hoping to make money making expensive drugs affordable for everyone.